Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study

ObjectivesPerfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) can be released of perfluorinated compounds by biotic and/or metabolic decomposition. Due to their ubiquitous occurrence, persistence and bioaccumulative properties they can be found in blood of the general population all over the world. In animal studies PFOS and PFOA provoked cancer and showed developmental toxic potential besides other adverse health effects. On the basis of the comparison of maternal and umbilical cord plasma sample pairs we wanted to examine whether infants are exposed to PFOS and PFOA via their mothers’ blood.MethodsWe determined PFOS and PFOA in 11 plasma samples of mothers and the 11 corresponding cord plasma samples of neonates. An analytical method based on plasma protein precipitation followed by HPLC with MS/MS-detection was employed. As internal standards we used 1,2,3,4-13C4-PFOS and 1,2-13C2-PFOA.ResultsWe found PFOS and PFOA in every plasma sample analysed. In maternal plasma samples PFOS concentrations were consistently higher compared to those of the related cord plasma samples (median: 13.0 μg/l vs. 7.3 μg/l). In the case of PFOA we observed only minor differences between PFOA concentrations within the analysed sample pairs (median: 2.6 μg/l vs. 3.4 μg/l for maternal and cord plasma samples, respectively).DiscussionFor both substances a crossing of the placental barrier could be shown. For PFOS we observed a decrease from maternal to cord plasma concentrations by a factor of 0.41–0.80. To the contrary, PFOA crosses the placental barrier obviously unhindered. These findings show that neonates are exposed to PFOS and PFOA via their mothers’ blood. Given the current situation that only little is known about the consequences of PFOS and PFOA exposure in the early state of development of humans and the fact that in animal studies both substances showed developmental toxic effects further research regarding human health effects is indispensable.

[1]  F. Benoit,et al.  A pilot study on the determination of perfluorooctanesulfonate and other perfluorinated compounds in blood of Canadians. , 2004, Journal of environmental monitoring : JEM.

[2]  Paul D. Jones,et al.  Accumulation of perfluorooctane sulfonate in marine mammals. , 2001, Environmental science & technology.

[3]  Jeffrey H Mandel,et al.  Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington. , 2004, Chemosphere.

[4]  M. Stanton,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  Jürgen Angerer,et al.  Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. , 2006, International journal of hygiene and environmental health.

[6]  Guibin Jiang,et al.  Perfluorooctanesulfonate and related fluorochemicals in human blood samples from China. , 2006, Environmental science & technology.

[7]  L. Hardell,et al.  Perfluoroalkylated compounds in whole blood andplasma from the Swedish population , 2004 .

[8]  Gerald L Kennedy,et al.  The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. , 2004, Toxicology.

[9]  Scott A Mabury,et al.  Fluorotelomer alcohol biodegradation yields poly- and perfluorinated acids. , 2004, Environmental science & technology.

[10]  Jeffrey H Mandel,et al.  Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.

[11]  J. Giesy,et al.  Peer Reviewed: Perfluorochemical Surfactants in the Environment , 2002 .

[12]  G. W. Jepson,et al.  Binding of perfluorooctanoic acid to rat and human plasma proteins. , 2003, Chemical research in toxicology.

[13]  C. Lau,et al.  Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. , 2003, Birth defects research. Part B, Developmental and reproductive toxicology.

[14]  C. Lau,et al.  The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.

[15]  T J Wallington,et al.  Formation of C7F15COOH (PFOA) and other perfluorocarboxylic acids during the atmospheric oxidation of 8:2 fluorotelomer alcohol. , 2006, Environmental science & technology.

[16]  P. Dayer,et al.  Changes in serum albumin and α1‐acid glycoprotein concentrations during pregnancy: an analysis of fetal‐maternal pairs , 1984, British journal of obstetrics and gynaecology.

[17]  A. Seacat,et al.  Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. , 2004, Chemical research in toxicology.

[18]  A. Calafat,et al.  Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk. , 2004, Environmental science & technology.

[19]  Timothy J Wallington,et al.  Degradation of fluorotelomer alcohols: a likely atmospheric source of perfluorinated carboxylic acids. , 2004, Environmental science & technology.

[20]  Jeffrey H Mandel,et al.  Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. , 2003, Environmental science & technology.

[21]  H Fromme,et al.  Occurrence of perfluorinated substances in an adult German population in southern Bavaria , 2007, International archives of occupational and environmental health.

[22]  M D Hill,et al.  The Significance of Plasma Protein Binding on the Fetal/Maternal Distribution of Drugs at Steady-State , 1988, Clinical pharmacokinetics.

[23]  A. Calafat,et al.  Perfluorinated chemicals in selected residents of the American continent. , 2006, Chemosphere.

[24]  Hongmei Qin,et al.  [Status of perfluorochemicals in adult serum and umbilical blood in Shenyang]. , 2004, Wei sheng yan jiu = Journal of hygiene research.

[25]  Kouji Harada,et al.  The Influence of Time, Sex and Geographic Factors on Levels of Perfluorooctane Sulfonate and Perfluorooctanoate in Human Serum over the Last 25 years , 2004, Journal of occupational health.

[26]  R. G. York,et al.  Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. , 2005, Toxicology.

[27]  Gerald L Kennedy,et al.  Perfluorooctanoate: Placental and lactational transport pharmacokinetics in rats. , 2005, Toxicology.

[28]  Noriko Yamanaka,et al.  Perfluorinated organic compounds in human blood serum and seminal plasma: a study of urban and rural tea worker populations in Sri Lanka. , 2005, Journal of environmental monitoring : JEM.

[29]  Fumio Okada,et al.  Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy , 2004, Environmental health perspectives.

[30]  Scott A Mabury,et al.  Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes. , 2005, Chemico-biological interactions.

[31]  M. A. Mohd,et al.  Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. , 2004, Environmental science & technology.

[32]  Scott A Mabury,et al.  Aqueous photolysis of 8:2 fluorotelomer alcohol , 2005, Environmental toxicology and chemistry.

[33]  C. Lau,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[34]  C. Lau,et al.  Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.

[35]  R. G. York,et al.  Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. , 2005, Toxicology.

[36]  J. Giesy,et al.  Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.

[37]  C. Lau,et al.  Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[38]  W. Good,et al.  THE DISTRIBUTION OF IMMUNOGLOBULINS AND ALBUMIN BETWEEN MATERNAL AND CORD SERUM AT DELIVERY , 1974 .